Open-Label, Dose-Escalation Study of 2 to 5 IM Doses of MEDI-524 at 3 mg/kg or 15 mg/kg; Children to be Followed for 90 Days After Their Last Dose of MEDI-524
Clinical trial NCT00192478 · COMPLETED
Trial details
- NCT number
- NCT00192478
- Sponsor
- MedImmune LLC
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-02-01
- Primary completion
- 2006-05-01
- Enrollment
- 217
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.